Chemours (NYSE: CC) reported Q2 EPS of $0.84, $0.01 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.49 billion.

For earnings history and earnings-related data on Chemours (CC) click here.